Novel variant in Sp7/Osx associated with recessive osteogenesis imperfecta with bone fragility and hearing impairment

Melissa Fiscaletti, Andrew Biggin, Bruce Bennetts, Karen Wong, Julie N. Briody, Verity Pacey, Catherine Birman, Craig Munns

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Osteogenesis imperfecta (OI) is a connective tissue disorder characterized by low bone density and recurrent fractures with a wide genotypic and phenotypic spectrum. Common features include short stature, opalescent teeth, blue sclerae and hearing impairment. The majority (>90%) of patients with OI have autosomal dominant variants in COL1A1/COL1A2, which lead to defects in type 1 collagen. More recently, numerous recessive variants involving other genes have also been identified. Sp7/Osx gene, is a protein coding gene that encodes a zinc finger transcription factor, osterix, which is a member of the Sp subfamily of sequence-specific DNA-binding proteins. Osterix is expressed primarily by osteoblasts and has been shown to be vital for bone formation and bone homeostasis by promoting osteoblast differentiation and maturation. In animal models, Sp7/Osx has also been shown to regulate biomineralization of otoliths, calcium carbonate structures found in the inner ear of vertebrates. Until recently, only one report of a boy with an Sp7/Osx pathogenic variant presenting with bone fragility, limb deformities and normal hearing has been described in the literature. We have identified a novel Sp7/Osx variant in another sibship that presented with osteoporosis, low-trauma fractures and short stature. Progressive moderate-to-severe and severe-to-profound hearing loss secondary to otospongiosis and poor mineralization of ossicles and petrous temporal bone was also noted in two of the siblings. A homozygous pathogenic variant in exon 2 of the Sp7/Osx gene was found in all affected relatives; c.946C>T (p.Arg316Cys). Bone biopsies in the proband and his male sibling revealed significant cortical porosity and high trabecular bone turnover. This is the second report to describe children with OI associated with an Sp7/Osx variant. However, it is the first to describe the bone histomorphometry associated with this disorder and identifies a significant hearing loss as a potential feature in this OI subtype. Early audiology screening in these children is therefore warranted.
LanguageEnglish
Pages66-75
Number of pages10
JournalBone
Volume110
DOIs
Publication statusPublished - May 2018

Fingerprint

Osteogenesis Imperfecta
Hearing Loss
Bone and Bones
Osteoblasts
Siblings
Petrous Bone
Audiology
Genes
Otolithic Membrane
Otosclerosis
Sclera
Calcium Carbonate
Bone Remodeling
Temporal Bone
Porosity
Zinc Fingers
DNA-Binding Proteins
Inner Ear
Collagen Type I
Osteogenesis

Keywords

  • Osteogenesis imperfecta
  • SP7/Osx
  • Osterix
  • Fractures
  • Hearing impairment

Cite this

Fiscaletti, Melissa ; Biggin, Andrew ; Bennetts, Bruce ; Wong, Karen ; Briody, Julie N. ; Pacey, Verity ; Birman, Catherine ; Munns, Craig. / Novel variant in Sp7/Osx associated with recessive osteogenesis imperfecta with bone fragility and hearing impairment. In: Bone. 2018 ; Vol. 110. pp. 66-75.
@article{5bcaebeb8f52419484be7efdad1d4a6d,
title = "Novel variant in Sp7/Osx associated with recessive osteogenesis imperfecta with bone fragility and hearing impairment",
abstract = "Osteogenesis imperfecta (OI) is a connective tissue disorder characterized by low bone density and recurrent fractures with a wide genotypic and phenotypic spectrum. Common features include short stature, opalescent teeth, blue sclerae and hearing impairment. The majority (>90{\%}) of patients with OI have autosomal dominant variants in COL1A1/COL1A2, which lead to defects in type 1 collagen. More recently, numerous recessive variants involving other genes have also been identified. Sp7/Osx gene, is a protein coding gene that encodes a zinc finger transcription factor, osterix, which is a member of the Sp subfamily of sequence-specific DNA-binding proteins. Osterix is expressed primarily by osteoblasts and has been shown to be vital for bone formation and bone homeostasis by promoting osteoblast differentiation and maturation. In animal models, Sp7/Osx has also been shown to regulate biomineralization of otoliths, calcium carbonate structures found in the inner ear of vertebrates. Until recently, only one report of a boy with an Sp7/Osx pathogenic variant presenting with bone fragility, limb deformities and normal hearing has been described in the literature. We have identified a novel Sp7/Osx variant in another sibship that presented with osteoporosis, low-trauma fractures and short stature. Progressive moderate-to-severe and severe-to-profound hearing loss secondary to otospongiosis and poor mineralization of ossicles and petrous temporal bone was also noted in two of the siblings. A homozygous pathogenic variant in exon 2 of the Sp7/Osx gene was found in all affected relatives; c.946C>T (p.Arg316Cys). Bone biopsies in the proband and his male sibling revealed significant cortical porosity and high trabecular bone turnover. This is the second report to describe children with OI associated with an Sp7/Osx variant. However, it is the first to describe the bone histomorphometry associated with this disorder and identifies a significant hearing loss as a potential feature in this OI subtype. Early audiology screening in these children is therefore warranted.",
keywords = "Osteogenesis imperfecta, SP7/Osx, Osterix, Fractures, Hearing impairment",
author = "Melissa Fiscaletti and Andrew Biggin and Bruce Bennetts and Karen Wong and Briody, {Julie N.} and Verity Pacey and Catherine Birman and Craig Munns",
year = "2018",
month = "5",
doi = "10.1016/j.bone.2018.01.031",
language = "English",
volume = "110",
pages = "66--75",
journal = "Bone",
issn = "1873-2763",
publisher = "Elsevier",

}

Novel variant in Sp7/Osx associated with recessive osteogenesis imperfecta with bone fragility and hearing impairment. / Fiscaletti, Melissa; Biggin, Andrew; Bennetts, Bruce; Wong, Karen; Briody, Julie N.; Pacey, Verity; Birman, Catherine; Munns, Craig.

In: Bone, Vol. 110, 05.2018, p. 66-75.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Novel variant in Sp7/Osx associated with recessive osteogenesis imperfecta with bone fragility and hearing impairment

AU - Fiscaletti, Melissa

AU - Biggin, Andrew

AU - Bennetts, Bruce

AU - Wong, Karen

AU - Briody, Julie N.

AU - Pacey, Verity

AU - Birman, Catherine

AU - Munns, Craig

PY - 2018/5

Y1 - 2018/5

N2 - Osteogenesis imperfecta (OI) is a connective tissue disorder characterized by low bone density and recurrent fractures with a wide genotypic and phenotypic spectrum. Common features include short stature, opalescent teeth, blue sclerae and hearing impairment. The majority (>90%) of patients with OI have autosomal dominant variants in COL1A1/COL1A2, which lead to defects in type 1 collagen. More recently, numerous recessive variants involving other genes have also been identified. Sp7/Osx gene, is a protein coding gene that encodes a zinc finger transcription factor, osterix, which is a member of the Sp subfamily of sequence-specific DNA-binding proteins. Osterix is expressed primarily by osteoblasts and has been shown to be vital for bone formation and bone homeostasis by promoting osteoblast differentiation and maturation. In animal models, Sp7/Osx has also been shown to regulate biomineralization of otoliths, calcium carbonate structures found in the inner ear of vertebrates. Until recently, only one report of a boy with an Sp7/Osx pathogenic variant presenting with bone fragility, limb deformities and normal hearing has been described in the literature. We have identified a novel Sp7/Osx variant in another sibship that presented with osteoporosis, low-trauma fractures and short stature. Progressive moderate-to-severe and severe-to-profound hearing loss secondary to otospongiosis and poor mineralization of ossicles and petrous temporal bone was also noted in two of the siblings. A homozygous pathogenic variant in exon 2 of the Sp7/Osx gene was found in all affected relatives; c.946C>T (p.Arg316Cys). Bone biopsies in the proband and his male sibling revealed significant cortical porosity and high trabecular bone turnover. This is the second report to describe children with OI associated with an Sp7/Osx variant. However, it is the first to describe the bone histomorphometry associated with this disorder and identifies a significant hearing loss as a potential feature in this OI subtype. Early audiology screening in these children is therefore warranted.

AB - Osteogenesis imperfecta (OI) is a connective tissue disorder characterized by low bone density and recurrent fractures with a wide genotypic and phenotypic spectrum. Common features include short stature, opalescent teeth, blue sclerae and hearing impairment. The majority (>90%) of patients with OI have autosomal dominant variants in COL1A1/COL1A2, which lead to defects in type 1 collagen. More recently, numerous recessive variants involving other genes have also been identified. Sp7/Osx gene, is a protein coding gene that encodes a zinc finger transcription factor, osterix, which is a member of the Sp subfamily of sequence-specific DNA-binding proteins. Osterix is expressed primarily by osteoblasts and has been shown to be vital for bone formation and bone homeostasis by promoting osteoblast differentiation and maturation. In animal models, Sp7/Osx has also been shown to regulate biomineralization of otoliths, calcium carbonate structures found in the inner ear of vertebrates. Until recently, only one report of a boy with an Sp7/Osx pathogenic variant presenting with bone fragility, limb deformities and normal hearing has been described in the literature. We have identified a novel Sp7/Osx variant in another sibship that presented with osteoporosis, low-trauma fractures and short stature. Progressive moderate-to-severe and severe-to-profound hearing loss secondary to otospongiosis and poor mineralization of ossicles and petrous temporal bone was also noted in two of the siblings. A homozygous pathogenic variant in exon 2 of the Sp7/Osx gene was found in all affected relatives; c.946C>T (p.Arg316Cys). Bone biopsies in the proband and his male sibling revealed significant cortical porosity and high trabecular bone turnover. This is the second report to describe children with OI associated with an Sp7/Osx variant. However, it is the first to describe the bone histomorphometry associated with this disorder and identifies a significant hearing loss as a potential feature in this OI subtype. Early audiology screening in these children is therefore warranted.

KW - Osteogenesis imperfecta

KW - SP7/Osx

KW - Osterix

KW - Fractures

KW - Hearing impairment

UR - http://www.scopus.com/inward/record.url?scp=85041633570&partnerID=8YFLogxK

U2 - 10.1016/j.bone.2018.01.031

DO - 10.1016/j.bone.2018.01.031

M3 - Article

VL - 110

SP - 66

EP - 75

JO - Bone

T2 - Bone

JF - Bone

SN - 1873-2763

ER -